In the current study, we use the same ELISA to verify whether levels of unmodified IAPP (hereon called uIAPP) in CSF are altered in a larger cohort of AD patients and moreover investigate if the CSF levels are associated with plasma levels of uIAPP, cognitive decline, AD biomarkers and Q-albumin (as a marker for BBB integrity). Here, ALB is linked to Alzheimer disease.